The natural history of multiple system atrophy: a prospective European cohort study, Lancet Neurol, vol.12, pp.264-274, 2013. ,
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study, Lancet, vol.354, pp.1771-1775, 1999. ,
Prevalence of multiple system atrophy, Lancet, vol.355, pp.495-496, 2000. ,
Neuroanatomical characteristics of the human pre-Botzinger complex and its involvement in neurodegenerative brainstem diseases, Brain, vol.134, pp.24-35, 2011. ,
Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death, Brain, vol.132, pp.1810-1819, 2009. ,
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, Ann N Y Acad Sci, vol.920, pp.16-27, 2000. ,
Expanding the spectrum of neuronal pathology in multiple system atrophy, Brain, vol.138, pp.2293-2309, 2015. ,
Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes, EMBO Rep, vol.3, pp.583-588, 2002. ,
Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration, Neuron, vol.45, pp.847-859, 2005. ,
Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy, J Neurosci, vol.25, pp.10689-10699, 2005. ,
Animal models of multiple system atrophy, Neuroscience, vol.211, pp.77-82, 2012. ,
Viral vectormediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease, Prog Brain Res, vol.184, pp.89-111, 2010. ,
Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques, Sci Rep, vol.2, p.253, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01053467
Glial promoter selectivity following AAV-delivery to the immature brain, PLoS One, vol.8, p.65646, 2013. ,
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons, Neurobiol Dis, vol.45, pp.939-953, 2012. ,
A cellular model to monitor proteasome dysfunction by alpha-synuclein, Biochemistry, vol.48, pp.8014-8022, 2009. ,
Production and titering of recombinant adeno-associated viral vectors, J Vis Exp, issue.57, p.3348, 2011. ,
Gene therapy vectors based on adeno-associated virus type 1, J Virol, vol.73, pp.3994-4003, 1999. ,
Recombinant adenoassociated virus purification using novel methods improves infectious titer and yield, Gene Ther, vol.6, pp.973-985, 1999. ,
Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences, Hum Gene Ther Methods, vol.23, pp.18-28, 2012. ,
Selective inactivation of striatal fosb/deltafosb-expressing neurons alleviates L-DOPA-Induced dyskinesia, Biol Psychiatry, vol.79, pp.354-361, 2016. ,
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking, J Clin Invest, vol.122, pp.3977-3989, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00956903
Targeting beta-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease, Proc Natl Acad Sci U S A, vol.112, pp.2517-2526, 2015. ,
Levodopa gains psychostimulant-like properties after nigral dopaminergic loss, Ann Neurol, vol.74, pp.140-144, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01153692
In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells, J Cell Mol Med, vol.22, pp.2536-2546, 2018. ,
Dégénérescences nigro-striées et cerebello-nigrostriées, 1961. ,
CSF alphasynuclein does not differentiate between parkinsonian disorders, Neurobiol Aging, vol.33, pp.1-3, 2012. ,
The neuropathology, pathophysiology and genetics of multiple system atrophy, Neuropathol Appl Neurobiol, vol.38, pp.4-24, 2012. ,
alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadateinduced phospholipase D activation in human embryonic kidney-293 cells, J Biol Chem, vol.277, pp.12334-12376, 2002. ,
AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models, Genes, vol.8, 2017. ,
Oligodendrocytes: Development, Physiology and Glucose Metabolism, Adv Neurobiol, vol.13, pp.275-294, 2016. ,
Pure autonomic failure in association with human alpha-synucleinopathy, Neurosci Lett, vol.296, pp.171-174, 2000. ,
Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes, Parkinsonism Relat Disord, vol.12, pp.356-62, 2006. ,
Striatal deformities of the hand and foot in Parkinson's disease, Lancet Neurol, vol.4, pp.423-454, 2005. ,
Alpha-synuclein mRNA expression in oligodendrocytes in MSA, Glia, vol.62, pp.964-70, 2014. ,
Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia, Parkinsonism Relat Disord, vol.21, pp.1273-1280, 2015. ,
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases, Neuron, vol.91, pp.56-66, 2016. ,
Transport of insulin across the bloodbrain barrier: saturability at euglycemic doses of insulin, Peptides, vol.18, pp.1423-1432, 1997. ,
Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines, J Neurochem, vol.85, pp.957-68, 2003. ,
Red blood cells are the major source of alpha-synuclein in blood, Neurodegener Dis, vol.5, pp.55-64, 2008. ,
Insulin resistance and exendin-4 treatment for multiple system atrophy, Brain, vol.140, pp.1420-1436, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01537233
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification, Prog Neurobiol, vol.118, pp.1-18, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01289729
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy, Proc Natl Acad Sci U S A, vol.113, pp.9593-9601, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01370967
Differential involvement of the periaqueductal gray in multiple system atrophy, Auton Neurosci, vol.158, pp.111-118, 2010. ,
Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy, Brain, vol.129, pp.2688-96, 2006. ,
Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease, Neurology, vol.66, pp.378-83, 2006. ,
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure, Ann Neurol, vol.43, pp.156-63, 1998. ,
Postural disorders in Parkinson's disease, Neurophysiol Clin, vol.38, pp.459-65, 2008. ,
, Pathophysiology of bradykinesia in Parkinson's disease, vol.124, pp.2131-2177, 2001.
Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland, J Neurol Neurosurg Psychiatry, vol.84, pp.136-176, 2013. ,
Lipid dysfunction and pathogenesis of multiple system atrophy, Acta Neuropathol Commun, vol.2, p.15, 2014. ,
Bladder dysfunction in a transgenic mouse model of multiple system atrophy, Mov Disord, vol.28, pp.347-55, 2013. ,
What lysosomes actually tell us about Parkinson's disease?, Ageing Res Rev, vol.32, pp.140-149, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02439406
Fighting neurodegeneration with rapamycin: mechanistic insights, Nat Rev Neurosci, vol.12, pp.437-52, 2011. ,
Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Neurology, vol.49, pp.1284-1292, 1976. ,
Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration, J Clin Invest, vol.126, pp.2970-88, 2016. ,
Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study, Mov Disord, vol.21, pp.159-65, 2006. ,
Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains, J Neurochem, vol.136, pp.172-85, 2016. ,
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy, Brain Res, vol.1326, pp.174-83, 2010. ,
The Synaptic Function of alpha-Synuclein, J Parkinsons Dis, vol.5, pp.699-713, 2015. ,
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro, Science, vol.329, pp.1663-1670, 2010. ,
Dopamine Transporter Activity Is Modulated by alpha-synuclein, J Biol Chem, 2015. ,
Double-knockout mice for alphaand beta-synucleins: effect on synaptic functions, Proc Natl Acad Sci U S A, vol.101, pp.14966-71, 2004. ,
alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity, J Biol Chem, vol.288, pp.7438-7487, 2013. ,
Insulin receptor signaling in the development of neuronal structure and function, Neural Dev, vol.5, p.7, 2010. ,
Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in, Neuroepidemiology, vol.23, pp.201-209, 2004. ,
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia, Circulation, vol.123, pp.1953-62, 2011. ,
Nonmotor presentations of multiple system atrophy, Nat Rev Neurol, vol.7, pp.295-303, 2011. ,
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders, Parkinsonism Relat Disord, vol.16, pp.142-147, 2010. ,
Anhidrosis in multiple system atrophy involves pre-and postganglionic sudomotor dysfunction, Mov Disord, vol.32, pp.397-404, 2017. ,
Direct observation of the interconversion of normal and toxic forms of alpha-synuclein, Cell, vol.149, pp.1048-59, 2012. ,
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alphasynucleinopathy, PLoS One, vol.5, p.9313, 2010. ,
Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging, Mov Disord, vol.22, pp.238-282, 2007. ,
Parkinson's disease: mechanisms and models, Neuron, vol.39, pp.889-909, 2003. ,
Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations, Lancet Neurol, vol.14, pp.855-866, 2015. ,
Pathogenic lysosomal depletion in Parkinson's disease, J Neurosci, vol.30, pp.12535-12579, 2010. ,
Alpha-synuclein-based models of Parkinson's disease, Rev Neurol, vol.172, pp.371-379, 2016. ,
, Lysosomal impairment in Parkinson's disease, vol.28, pp.725-757, 2013.
L'atrophie olivo-ponto-cérébelleuse, pp.424-427, 1900. ,
Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia, Clin Ther, vol.30, pp.1956-75, 2008. ,
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein, Proc Natl Acad Sci U S A, vol.106, pp.13010-13015, 2009. ,
Beta-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007. ,
Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models, Stem Cell Reports, vol.5, pp.174-84, 2015. ,
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy, Acta Neuropathol Commun, vol.2, p.150, 2014. ,
Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis, Infection, vol.24, pp.125-134, 1996. ,
Insulin receptor signaling in long-term memory consolidation following spatial learning, Learn Mem, vol.12, pp.646-55, 2005. ,
Protein degradation pathways in Parkinson's disease: curse or blessing, Acta Neuropathol, vol.124, pp.153-72, 2012. ,
Alpha-synuclein structure, functions, and interactions, J Res Med Sci, vol.21, p.29, 2016. ,
Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells, Mol Cell Neurosci, vol.62, pp.68-78, 2014. ,
Multiple-system atrophy, N Engl J Med, vol.372, pp.1375-1381, 2015. ,
Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts, Acta Neuropathol, vol.121, pp.675-93, 2011. ,
Sleep dysfunction in multiple system atrophy, Curr Treat Options Neurol, vol.14, pp.464-73, 2012. ,
Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy, Synapse, vol.68, pp.98-106, 2014. ,
Animal models of multiple system atrophy, Neuroscience, vol.211, pp.77-82, 2012. ,
Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy, Mov Disord, vol.29, pp.388-95, 2014. ,
Assessment of sensorimotor function in mouse models of Parkinson's disease, J Vis Exp, 2013. ,
Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome, J Clin Invest, vol.9, pp.65-74, 2014. ,
Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?, Acta Neuropathol, vol.116, pp.269-75, 2008. ,
alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat Cell Biol, vol.4, pp.160-164, 2002. ,
Brain proteasomal function in sporadic Parkinson's disease and related disorders, Ann Neurol, vol.51, pp.779-82, 2002. ,
alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy, Exp Neurol, vol.181, pp.68-78, 2003. ,
Synucleinopathies: clinical and pathological implications, Arch Neurol, vol.58, pp.186-90, 2001. ,
The North American Multiple System Atrophy Study Group, J Neural Transm, vol.112, pp.1687-94, 2005. ,
Second consensus statement on the diagnosis of multiple system atrophy, vol.71, pp.670-676, 2008. ,
Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases, J Clin Invest, vol.121, pp.3320-3350, 2011. ,
Identifying specific receptors for cargo-mediated autophagy, Cell Res, vol.24, pp.783-787, 2014. ,
Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin, J Cell Biol, vol.152, pp.579-94, 2001. ,
Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy, J Neurol Neurosurg Psychiatry, vol.32, pp.28-34, 1969. ,
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells, Cell Mol Neurobiol, vol.28, pp.35-47, 2008. ,
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders, Arch Neurol, vol.69, pp.1445-52, 2012. ,
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder, Neurology, vol.88, pp.930-937, 2017. ,
Structure, regulation, signaling, and targeting of abl kinases in cancer, Genes Cancer, vol.3, pp.436-482, 2012. ,
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD, Proc Natl Acad Sci U S A, vol.98, pp.9666-70, 2001. ,
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature, vol.460, pp.392-397, 2009. ,
Distinct Parameters in the EEG of the PLP alpha-SYN Mouse Model for Multiple System Atrophy Reinforce Face Validity, Front Behav Neurosci, vol.10, p.252, 2016. ,
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in Parkinson's disease models, Hum Mol Genet, vol.22, pp.3315-3343, 2013. ,
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease, J Neurosci, vol.31, pp.157-63, 2011. ,
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders, Front Neurosci, vol.10, p.408, 2016. ,
The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems, Acta Neuropathol, vol.93, pp.585-91, 1997. ,
Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system), Neuropathology, vol.28, pp.249-57, 2008. ,
Microglial activation parallels system degeneration in multiple system atrophy, J Neuropathol Exp Neurol, vol.63, pp.43-52, 2004. ,
Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation, Front Cell Neurosci, vol.11, p.24, 2017. ,
Identification of two distinct synucleins from human brain, FEBS Lett, vol.345, pp.27-32, 1994. ,
Parkinson's disease: clinical features and diagnosis, J Neurol Neurosurg Psychiatry, vol.79, pp.368-76, 2008. ,
Premotor signs and symptoms of multiple system atrophy, Lancet Neurol, vol.11, pp.361-369, 2012. ,
Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy, J Med Dent Sci, vol.55, pp.145-53, 2008. ,
mTOR regulation of autophagy, FEBS Lett, vol.584, pp.1287-95, 2010. ,
Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes, EMBO Rep, vol.3, pp.583-591, 2002. ,
The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease, 2014. ,
Natural history of pure autonomic failure: A United States prospective cohort, Ann Neurol, vol.81, pp.287-297, 2017. ,
Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies, J Neuropathol Exp Neurol, vol.67, pp.984-93, 2008. ,
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat Cell Biol, vol.13, pp.132-173, 2011. ,
Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia, Neurobiol Aging, vol.29, pp.739-52, 2008. ,
Autophagy and p70S6 kinase, Autophagy, vol.1, pp.59-60, 2005. ,
Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway, Autophagy, vol.8, pp.754-66, 2012. ,
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function, Proc Natl Acad Sci U S A, vol.107, pp.16691-16697, 2010. ,
Presentation, diagnosis, and management of multiple system atrophy in Europe, Mov Disord, vol.25, pp.2604-2616, 2010. ,
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat Med, vol.14, pp.504-510, 2008. ,
FAS-dependent cell death in alpha-synuclein transgenic oligodendrocyte models of multiple system atrophy, PLoS One, vol.8, p.55243, 2013. ,
Kinetic tremor in Parkinson's disease--an underrated symptom, J Neural Transm, vol.113, pp.845-53, 2006. ,
Multiple system atrophy: insights into a rare and debilitating movement disorder, Nat Rev Neurol, vol.13, pp.232-243, 2017. ,
Towards translational therapies for multiple system atrophy, Prog Neurobiol, vol.118, pp.19-35, 2014. ,
Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence, Exp Neurol, vol.247, pp.531-537, 2013. ,
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target, Nat Rev Neurosci, vol.14, pp.38-48, 2013. ,
, Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative, vol.80, pp.29-41, 2015.
Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J Neurosci, vol.25, pp.6016-6040, 2005. ,
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein, Int J Biochem Cell Biol, vol.40, pp.1835-1884, 2008. ,
Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies, J Biol Chem, vol.285, pp.9262-72, 2010. ,
Cell-to-cell transmission of alphasynuclein aggregates, Methods Mol Biol, vol.849, pp.347-59, 2012. ,
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat Med, vol.14, pp.501-504, 2008. ,
, Minimal change multiple system atrophy: an aggressive variant, vol.30, pp.960-967, 2015.
Ubiquitination increases parkin activity to promote autophagic alpha-synuclein clearance, PLoS One, vol.8, p.83914, 2013. ,
Current Treatment of Multiple System Atrophy, Curr Treat Options Neurol, vol.18, p.51, 2016. ,
A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers, Biochemistry, vol.45, pp.5783-92, 2006. ,
Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation, Parkinsons Dis, p.9832839, 2016. ,
c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson's disease, Hum Mol Genet, vol.23, pp.2858-79, 2014. ,
Review of tremor in Parkinson's disease and atypical parkinsonian disorders, Neurol India, vol.65, pp.1083-1090, 2017. ,
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J Neurosci, vol.30, pp.1166-75, 2010. ,
Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization, Neuron, vol.25, pp.649-62, 2000. ,
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates, Acta Neuropathol Commun, vol.5, p.47, 2017. ,
Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors, J Neurosci, vol.29, pp.6734-51, 2009. ,
Clinical overview of the synucleinopathies, Mov Disord, issue.6, pp.21-28, 2003. ,
Gastrointestinal dysfunction in multiple system atrophy, Semin Neurol, vol.16, pp.251-259, 1996. ,
Myelin degeneration in multiple system atrophy detected by unique antibodies, Am J Pathol, vol.153, pp.735-779, 1998. ,
alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy, Neurobiol Aging, vol.35, pp.2357-68, 2014. ,
G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis, Cell Signal, vol.41, pp.25-32, 2018. ,
Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance, Arch Physiol Biochem, vol.117, pp.125-155, 2011. ,
, Parkinsonism Relat Disord, issue.1, pp.62-69, 1920.
First symptoms in multiple system atrophy, Clin Auton Res, vol.28, pp.215-221, 2018. ,
Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy, Sleep Med, vol.15, pp.476-485, 2014. ,
Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death, Neuroscience, vol.143, pp.165-73, 2006. ,
AMBRA1, a novel alpha-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy, Brain Pathol, vol.28, pp.28-42, 2018. ,
Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia, J Neural Transm, vol.112, pp.1613-1637, 2005. ,
How to interpret LC3 immunoblotting, Autophagy, vol.3, pp.542-547, 2007. ,
alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study, Lancet Neurol, vol.10, pp.230-270, 2011. ,
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling, Neurobiol Aging, vol.31, pp.224-267, 2010. ,
CSF alpha-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders, Parkinsonism Relat Disord, vol.20, pp.382-389, 2014. ,
Alpha-synuclein and tau: teammates in neurodegeneration?, Mol Neurodegener, vol.9, p.43, 2014. ,
A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy, Neuropathol Appl Neurobiol, vol.30, pp.546-54, 2004. ,
Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type, Mov Disord, vol.18, pp.430-432, 2003. ,
Relocation of p25alpha/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy, Acta Neuropathol Commun, vol.2, p.136, 2014. ,
Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy, Acta Neuropathol, vol.102, pp.188-90, 2001. ,
Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma, J Neurol Sci, vol.154, pp.116-137, 1998. ,
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations, Brain, vol.127, pp.2657-71, 2004. ,
Laryngeal stridor in multiple system atrophy: Clinicopathological features and causal hypotheses, J Neurol Sci, vol.361, pp.243-252, 2016. ,
Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies, J Parkinsons Dis, vol.6, pp.503-520, 2016. ,
Diagnosis of multiple system atrophy, Auton Neurosci, vol.211, pp.15-25, 2018. ,
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome), J Neurol Sci, vol.94, pp.79-100, 1989. ,
Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease, Glia, vol.56, pp.1215-1238, 2008. ,
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system, Mov Disord, vol.25, pp.2621-2627, 2010. ,
A role for alphasynuclein in the regulation of dopamine biosynthesis, J Neurosci, vol.22, pp.3090-3099, 2002. ,
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy, J Neurol Sci, vol.279, pp.76-85, 2009. ,
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2052, 1997. ,
SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy, Neurosci Lett, vol.381, pp.74-83, 2005. ,
Physiological roles of G protein-coupled receptor kinases and arrestins, Annu Rev Physiol, vol.69, pp.511-545, 2007. ,
Ubiquitin-positive inclusions in different types of multiple system atrophy: distribution and specificity, Pathol Res Pract, vol.192, pp.453-61, 1996. ,
Cell death mechanisms in multiple system atrophy, J Neuropathol Exp Neurol, vol.57, pp.814-835, 1998. ,
mTOR and lysosome regulation, 1000. ,
A short clinical history of multiple system atrophy, Clin Auton Res, vol.25, pp.3-7, 2015. ,
The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to alpha-synuclein inclusions, Mol Cell Neurosci, vol.65, pp.68-81, 2015. ,
Intestinal epithelium and autophagy: partners in gut homeostasis, Front Immunol, vol.4, p.301, 2013. ,
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease, Nat Rev Neurosci, vol.11, pp.760-72, 2010. ,
Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies, Acta Neuropathol Commun, vol.6, issue.2, 2018. ,
Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure, Eur J Clin Invest, vol.45, pp.187-95, 2015. ,
Alpha-synuclein transfers from neurons to oligodendrocytes, Glia, vol.62, pp.387-98, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01181201
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease, J Neurochem, vol.104, pp.1504-1529, 2008. ,
Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination, Mol Cell Neurosci, vol.21, pp.223-261, 2002. ,
Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival, J Neural Transm, vol.121, pp.507-519, 2014. ,
Pathology of the inferior olivary nucleus in patients with multiple system atrophy, Acta Neuropathol, vol.103, pp.550-554, 2002. ,
Epidemiology of Multiple System Atrophy in Hokkaido, the Northernmost Island of Japan, Cerebellum, vol.14, pp.682-689, 2015. ,
Targeted therapies and autophagy: new insights from chronic myeloid leukemia, Autophagy, vol.5, pp.1050-1051, 2009. ,
Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy, Sci Signal, vol.2, pp.368-73, 2008. ,
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study, Lancet, vol.354, pp.1771-1776, 1999. ,
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport, J Clin Invest, vol.88, pp.1272-81, 1991. ,
Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes, J Mol Neurosci, vol.47, pp.256-66, 2012. ,
Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases, Biochim Biophys Acta, vol.1833, 1992. ,
BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription, Blood, vol.118, pp.2840-2848, 2011. ,
Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nat Rev Mol Cell Biol, vol.15, pp.155-62, 2014. ,
A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study, Arch Neurol, vol.2, pp.511-538, 1960. ,
Oligodendrocytes: Myelination and Axonal Support, Cold Spring Harb Perspect Biol, vol.8, p.20479, 2015. ,
p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy, Am J Pathol, vol.171, pp.1291-303, 2007. ,
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies, Neurosci Lett, vol.251, pp.205-213, 1998. ,
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies, Proc Natl Acad Sci U S A, vol.95, pp.6469-73, 1998. ,
Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35, Genomics, vol.27, pp.379-81, 1995. ,
Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-879, 1997. ,
, Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group, vol.29, pp.857-67, 2014.
Microglial activation mediates neurodegeneration related to oligodendroglial alphasynucleinopathy: implications for multiple system atrophy, Mov Disord, vol.22, pp.2196-203, 2007. ,
Animal models of multiple system atrophy, Clin Auton Res, vol.25, pp.9-17, 2015. ,
Review: Multiple system atrophy: emerging targets for interventional therapies, Neuropathol Appl Neurobiol, vol.42, pp.20-32, 2016. ,
Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure, Exp Neurol, vol.224, pp.459-64, 2010. ,
Cargo recognition and trafficking in selective autophagy, Nat Cell Biol, vol.16, pp.495-501, 2014. ,
Synuclein activates microglia in a model of Parkinson's disease, Neurobiol Aging, vol.29, pp.1690-701, 2008. ,
alpha-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter, J Biol Chem, vol.286, pp.43933-43976, 2011. ,
Dopamine metabolism and reactive oxygen species production, Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease, 2016. ,
G protein-coupled receptor kinase 2, with beta-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta, Diabetes, vol.61, pp.1978-85, 2012. ,
Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective, J Biol Chem, vol.279, pp.4625-4656, 2004. ,
Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test, J Neurol, vol.259, pp.1448-52, 2012. ,
Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy, J Biol Chem, vol.288, pp.15194-210, 2013. ,
Alteration of autophagosomal proteins in the brain of multiple system atrophy, Neurobiol Dis, vol.49, pp.190-198, 2013. ,
Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease, J Neuropathol Exp Neurol, vol.67, pp.1149-58, 2008. ,
, Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease, vol.17, pp.701-710, 2002.
Brain alphasynuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation, Brain, vol.133, pp.172-88, 2010. ,
The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis, Int J Clin Exp Pathol, vol.5, pp.726-764, 2012. ,
Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors, J Neurosci, vol.30, pp.6236-6282, 2010. ,
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci U S A, vol.90, pp.11282-11288, 1993. ,
GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation, EMBO J, vol.23, pp.2821-2830, 2004. ,
The neuropathology of multiple system atrophy and its therapeutic implications, Auton Neurosci, vol.211, pp.1-6, 2018. ,
MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy, Front Mol Neurosci, vol.10, p.329, 2017. ,
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy, Glia, vol.62, pp.317-354, 2014. ,
Viral vector-based models of Parkinson's disease, Curr Top Behav Neurosci, vol.22, pp.271-301, 2015. ,
Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins, J Biol Chem, vol.285, pp.32486-93, 2010. ,
Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2, Sci Signal, vol.8, p.73, 2015. ,
Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells, J Biol Chem, vol.283, pp.23542-56, 2008. ,
Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, vol.72, pp.57-71, 2011. ,
Glial promoter selectivity following AAV-delivery to the immature brain, PLoS One, vol.8, p.65646, 2013. ,
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration, Nat Rev Neurosci, vol.17, pp.251-60, 2016. ,
19F NMR studies of alpha-synuclein-membrane interactions, Protein Sci, vol.19, pp.1686-91, 2010. ,
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients, Brain, vol.125, pp.1070-83, 2002. ,
Alpha-Synuclein is degraded by both autophagy and the proteasome, J Biol Chem, vol.278, pp.25009-25022, 2003. ,
Cloning and characterization of the rat myelin basic protein gene promoter, Gene, vol.313, pp.161-168, 2003. ,
Clinicopathological study of 35 cases of multiple system atrophy, J Neurol Neurosurg Psychiatry, vol.58, pp.160-166, 1995. ,
, The natural history of multiple system atrophy: a prospective European cohort study, vol.12, pp.264-74, 2013.
Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study, Cerebellum, vol.11, pp.223-229, 2012. ,
A novel grading scale for striatonigral degeneration (multiple system atrophy), J Neural Transm, vol.109, pp.307-327, 2002. ,
Multiple system atrophy: a primary oligodendrogliopathy, Ann Neurol, vol.64, pp.239-285, 2008. ,
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS), Mov Disord, vol.19, pp.1391-402, 2004. ,
Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein, Eur J Neurosci, vol.24, pp.55-64, 2006. ,
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study, J Neurol, vol.265, pp.1618-1624, 2018. ,
In vivo demonstration that alpha-synuclein oligomers are toxic, Proc Natl Acad Sci U S A, vol.108, pp.4194-4203, 2011. ,
alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease, J Cell Biol, vol.190, pp.1023-1060, 2010. ,
The Parkinson disease protein alpha-synuclein inhibits autophagy, Autophagy, vol.7, pp.429-460, 2011. ,
Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study, Mov Disord, vol.25, pp.349-56, 2010. ,
Nilotinib -Differentiating the Hope from the Hype, J Parkinsons Dis, vol.6, pp.519-541, 2016. ,
Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies, Mov Disord, vol.31, pp.178-92, 2016. ,
Synucleinopathies: common features and hippocampal manifestations, Cell Mol Life Sci, vol.74, pp.1485-1501, 2017. ,
Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei, Neuropathology, vol.21, pp.145-54, 2001. ,
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling, Nutrients, p.9, 2017. ,
Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation, J Biol Chem, vol.288, pp.18249-59, 2013. ,
alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons, J Cell Sci, vol.128, pp.2231-2274, 2015. ,
Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes, Parkinsonism Relat Disord, vol.35, pp.63-68, 2017. ,
Causes of Death in Chinese Patients with Multiple System Atrophy, Aging Dis, vol.9, pp.102-108, 2018. ,
Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J, vol.19, pp.533-575, 2005. ,